ALPS ADVISORS INC AVBP — ARRIVENT BIOPHARMA INC

Ownership history in ALPS ADVISORS INC  ·  6 quarters on record

AI Ownership Summary

ALPS ADVISORS INC reported ARRIVENT BIOPHARMA INC (AVBP) in 6 quarterly 13F filings from 2024 Q2 through 2026 Q1. The latest visible filing shows AVBP at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this AVBP ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was ALPS ADVISORS INC's position in ARRIVENT BIOPHARMA INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

AVBP was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2024 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q2 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

AVBP stock page ALPS ADVISORS INC fund profile ALPS ADVISORS INC full holdings
How ALPS ADVISORS INC held AVBP — position size vs. price
% of Fund (quarterly)    AVBP price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 6 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 ADDED — — — 35,986 +2,090 +6.2% 0.00% $830K 2026-05-08 $29.50
2025 Q4 ADDED — — — 33,896 +8,729 +34.7% 0.00% $682K 2026-02-12 $22.42
2025 Q1 REDUCED 7.7% +17.7% ❌ 25,167 -2,085 -7.7% 0.00% $465K 2025-04-30 $21.26
2024 Q4 REDUCED — — — 27,252 -181 -0.7% 0.00% $726K 2025-02-13 $26.85
2024 Q3 ADDED — — — 27,433 +1,294 +5.0% 0.00% $645K 2024-11-12 $32.99
2024 Q2 INITIATED — — — 26,139 — — 0.00% $485K 2024-08-13 $23.11

🏢 Other funds also holding AVBP

As of 2026 Q1 — sorted by position size

MOODY ALDRICH PARTNERS LLC 3Y 7Y 0.23% Optimize Financial Inc 0.21% IvyRock Asset Management (HK) Ltd 3Y 0.21% Persistent Asset Partners Ltd 0.07% E Fund Management Co., Ltd. 3Y 0.06% PROFUND ADVISORS LLC 3Y 7Y 0.01% China Universal Asset Management Co., Ltd. 3Y 0.01% Brooklyn Investment Group 0.01% AlphaQuest LLC 0.0% INTECH INVESTMENT MANAGEMENT LLC 3Y 0.0%

FAQ About ALPS ADVISORS INC and AVBP

These are the practical questions this page is built to answer before you even open the full history table.

How long has ALPS ADVISORS INC reported owning AVBP?

ALPS ADVISORS INC reported AVBP across 6 quarterly 13F filings, from 2024 Q2 through 2026 Q1.

What was the largest reported AVBP position in ALPS ADVISORS INC's portfolio?

The largest reported portfolio weight for AVBP was 0.00% in 2024 Q4.

What is the latest reported AVBP position on this page?

The most recent filing on this page is 2026 Q1, when ALPS ADVISORS INC reported 35,986 shares, equal to 0.00% of portfolio, with an estimated market value of $830K.

What does the chart on this AVBP ownership page compare?

The chart compares ALPS ADVISORS INC's quarterly AVBP portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did ALPS ADVISORS INC time their AVBP position?

Based on 13F filing dates vs. subsequent AVBP price moves, ALPS ADVISORS INC correctly timed 3 out of 5 reported position changes (60%). The annualised alpha on AVBP relative to SPY over the holding period was +8.4%.

← Back to ALPS ADVISORS INC Holdings